Home-based electronic cardiac rehabilitation program for patients with coronary artery disease
eCardiacRehab - a Pragmatic Trial on a Home-based Patient-centered e-Health Programme With Tailored Solutions - Feasibility Study
This study is testing a new online heart rehab program to see if it can help people with coronary artery disease recover better at home after their heart procedure.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Haukeland University Hospital Academic / other |
| Locations | 1 site (Bergen) |
| Trial ID | NCT06759805 on ClinicalTrials.gov |
What this trial studies
This study aims to develop and evaluate the efficacy and cost-effectiveness of an interdisciplinary home-based electronic cardiac rehabilitation program, known as eCardiacRehab, for patients with coronary artery disease following percutaneous coronary intervention. Given the low participation rates in traditional cardiac rehabilitation programs, the study seeks to address barriers to access, particularly for older adults and women. The program will utilize digital tools to enhance patient engagement and support their rehabilitation needs, ultimately aiming to improve health outcomes and quality of life. The study will involve Norwegian-speaking adults who have undergone PCI and have internet access.
Who should consider this trial
Good fit: Ideal candidates include Norwegian-speaking adults aged 18 and older with coronary artery disease who have undergone PCI and have internet access.
Not a fit: Patients with cognitive impairments, severe arrhythmias, or those who are clinically unstable may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly increase access to cardiac rehabilitation for patients, leading to improved health outcomes and quality of life.
How similar studies have performed: Other studies have shown success with home-based rehabilitation programs, indicating potential for this approach to improve patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult Norwegian (or Scandinavian) speaking patients (≥ 18 years) who have a Norwegian national identification number, * With coronary artery disease after percutaneous coronary intervention * Are living at home and have internet available to them * Providing signed informed consent Exclusion Criteria: * Patients with cognitive impairment that may interfere with the ability to comply with the study protocol * Severe aortic stenosis * Severe arrhythmias * Expected lifetime less than one year as determined by study personnel * Otherwise clinically unstable * Not fully revascularized (awaits percutaneous coronary intervention or coronary artery bypass graft surgery) * Inability to comply with the study protocol due to any physical disability, somatic disease, or mental problems as determined by study personnel
Where this trial is running
Bergen
- Haukeland University Hospital — Bergen, Norway (Recruiting)
Study contacts
- Principal investigator: Tone M Norekvål, PhD — Haukeland University Hospital
- Study coordinator: Trond R Pettersen, PhD
- Email: trond.roed.pettersen@helse-bergen.no
- Phone: 004748124938
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.